Update on WTX-124 Phase 1/1b clinical trial interim data and End of Phase 1 meeting with the U.S. Food & Drug Administration ...
CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $23.1 million, or $0.24 per diluted share, in 3Q25 compared to $9.3 million or $0.09 per diluted share, in 3Q24. Non-economic ...
Marvell Technology, Inc.'s financials show record data center revenue, improving margins, and a bullish outlook. Learn more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback